Journal of the California Cannabis Research Medical
Ricky Williams Protests Drug
Testing by Quitting Football, by Fred Gardner
From Ricky Williams Journal
Cannabinoid Antagonist Will
be Sold as Diet Drug, by Fred Gardner
ICRS 2004: 10 Talks
of Special Interest to Dr. X
About the MMPU, by Pebbles
Why I'm Starting MedBoardWatch.Com,
by Frank Lucido MD with Fred Gardner
Privacy Wins in Bearman
Honor Complexity, by
Andrew Weil, MD
"Marijuana Use Disorders"
California MJ Research
Program Stretches Mandate to Hold "Cannabinoid Therapeutics" Event
in Italy, by Fred Gardner
Medical Board Says it
Won't Investigate Doctors Just for Approving Cannabis Use; So Why
is Dr. Tod Being Punished?, by Fred Gardner
Medical Board Got Records from DEA Illegally,
California and U.S.
Officials Conspired to Block Prop 215, by Patrick McCartney
The "Affirmative Defense" Strategy
Dr. Leveque's Unspoken
Message to Congress
A Reluctant Martyr: Marian
Fry, MD, O'Shaughnessy's News Service
Pat Humphrey: His Brother's
Keeper, KZFR Interview
Understanding Plant Canopy
Measurements, by Dianna Katherine Dearborn
What's in a Name?
At the Spring meeting of the California Cannabis Research Medical Group, Philip
A. Denney, MD, questioned whether the name really applied to doctors who are
independent practitioners. The appropriateness of "California" was
also discussed, since doctors in other states -and countries- are treating
and consulting with patients who use cannabis as medicine. And shouldn't the
second "C" word be "Cannabinoids?" to include compounds
made in the lab and in the body?
Jeff Hergenrather, MD, thinks the CCRMG name works. The member-doctors may have
disparate and diverse practices, but they have a common interest in studying
the clinical applications of cannabis, i.e., doing research. So it stands, for
now. Doctors and others who want to learn more about the CCRMG should contact
info<AT>ccrmg.org or John Trapp at 510-548-1188.
O'Shaughnessy's seeks to be a forum for doctors, nurses, caregivers and patients
who are interested in the clinical applications of cannabis.
The main goal of this issue is to confront and demolish the lie perpetrated by
the U.S. Drug Enforcement Association that there have been thousands of studies
showing cannabis to be harmful and none showing beneficial medical effect.
Copies or bundles of O'Shaughnessy's are available to physicians for distribution
to patients. A sound doctor-patient relationship requires a level of honesty
that Prohibition makes very difficult to achieve. Placing O'Shaughnessy's in
the waiting room is a good way to "break the ice" and encourage patients
to confide about their cannabis use.
To be listed as a supporter, or to get involved as a contributor, a distributor,
or on any other level, please contact 510-548-1188 or journal<AT>ccrmg.org.
Our mailing address is p.o. box 9143 Berkeley CA 94709.
The paper is online at http//www.ccrmg.org
Subscriptions are $12 for four issues.
Fred Gardner, Managing Editor